The relationship between the daily dose, the plasma concentration of AD-5423 (blonanserin), and its plasma anti-dopamine (D2) and anti-serotonin (5-HT2A) activity, and the plasma serotonin/dopamine (S/D) ratio

被引：1
|
作者：
Suzuki, H [1 ]
Morokawa, Y [1 ]
Gen, K [1 ]
Takagi, H [1 ]
Yamaguchi, N [1 ]
Tanaka, C [1 ]
Aoba, A [1 ]
机构：
[1] St Marianna Univ, Sch Med, Dept Neuropsychiat, Kawasaki, Kanagawa, Japan
来源：
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 2003年 / 18卷 / 03期
关键词：
D O I：
10.1097/00004850-200305000-00039
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [21] Novel, highly potent and selective serotonin 5-HT2A/dopamine D2 receptor antagonists as potential antipsychotics.
    Lee, TK
    Robichaud, AJ
    Boyle, KE
    Lu, YM
    Chen, WT
    McClung, C
    Deng, W
    Miller, KJ
    McElroy, JF
    Largent, BL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U17 - U17
  • [22] Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
    Akash Rathore
    Vivek Asati
    Mitali Mishra
    Ratnesh Das
    Varsha Kashaw
    Sushil Kumar Kashaw
    In Silico Pharmacology, 10 (1)
  • [23] Effect of clozapine on the dimerization of serotonin 5-HT2A receptor and its genetic variant 5-HT2AH425Y with dopamine D2 receptor
    Lukasiewicz, Sylwia
    Faron-Gorecka, Agata
    Kedracka-Krok, Sylwia
    Dziedzicka-Wasylewska, Marta
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 114 - 123
  • [24] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Ragy R. Girgis
    Andy Forbes
    Anissa Abi-Dargham
    Mark Slifstein
    Neuropsychopharmacology, 2020, 45 : 786 - 792
  • [25] A positron emission tomography occupancy study of brexpiprazole at dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors, and serotonin reuptake transporters in subjects with schizophrenia
    Girgis, Ragy R.
    Forbes, Andy
    Abi-Dargham, Anissa
    Slifstein, Mark
    NEUROPSYCHOPHARMACOLOGY, 2020, 45 (05) : 786 - 792
  • [26] Comparison of the mean anti-D2 activity, the mean anti-5-HT2A activity and the mean anti-5-HT2A activity/anti-D2 activity (S/D) ratio in plasma of between typical antipsychotic agents and atypical antipsychotic agents
    Suzuki, H
    Morokawa, Y
    Gen, K
    Kamimura, M
    Takagi, H
    Yamaguchi, N
    Aoba, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S6 - S6
  • [27] Effects of olanzapine and betahistine co-treatment on serotonin transporter, 5-HT2A and dopamine D2 receptor binding density
    Lian, Jiamei
    Huang, Xu-Feng
    Pai, Nagesh
    Deng, Chao
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 47 : 62 - 68
  • [28] Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain
    I. Kusumi
    Y. Takahashi
    K. Suzuki
    K. Kameda
    T. Koyama
    Journal of Neural Transmission, 2000, 107 : 295 - 302
  • [29] Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain
    Kusumi, I
    Takahashi, Y
    Suzuki, K
    Kameda, K
    Koyama, T
    JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (03) : 295 - 302
  • [30] Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics
    Blasi, Giuseppe
    Selvaggi, Pierluigi
    Fazio, Leonardo
    Antonucci, Linda Antonella
    Taurisano, Paolo
    Masellis, Rita
    Romano, Raffaella
    Mancini, Marina
    Zhang, Fengyu
    Caforio, Grazia
    Popolizio, Teresa
    Apud, Jose
    Weinberger, Daniel R.
    Bertolino, Alessandro
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (07) : 1600 - 1608
12345